Vysis, Roche deal

ROCZ will use VYSI's PathVysion HER2 breast cancer test kit with Herceptin, an anti-HER-2 monoclonal antibody developed by Genentech Inc. (DNA, South San Francisco, Calif.) and marketed by ROCZ out...